GRTXD · Galera Therapeutics, Inc. · Exempt Offerings
$18.99
At close · Aug 3
Return incl. dividend (before tax)
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, there is substantial doubt about our ability to continue as a going concern through the 12 months from the date of the filing of this Quarterly Report on Form 10-Q.”View the 10-Q filed May 14, 2026
Market Cap
$15.23M
Shares
802,149
Volume · Aug 3
2447
Avg daily vol (6 sessions)
1267
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.